The Australia MarCom Report
SEE OTHER BRANDS

Fresh news on media and advertising in Australia

Reporting terrible events happening at top of world

(MENAFN) A controversial high-speed ascent of Mount Everest by four former British special forces soldiers has sparked an investigation in Nepal. The team reached the summit in less than five days, reportedly without completing the customary acclimatization process that typically takes several weeks.

The unprecedented feat has raised suspicions that the climbers may have used Xenon gas—a substance believed to help bypass the need for gradual adaptation to high altitudes. In response to media coverage, Nepal’s Ministry of Culture, Tourism and Civil Aviation has launched a probe into the allegations.

The Department of Tourism stated it is working with expedition leaders, team members, and agencies to collect information and thoroughly examine the matter. Director Himal Gautam emphasized that all mountaineers must declare any substances, medications, or equipment they use during climbs.

While record-setting may be a factor, the increasing danger on Everest—exacerbated by climate change and rising avalanche risk—is also believed to be influencing climbers’ decisions to ascend more quickly.

The spring climbing season in Nepal typically runs from April through May and attracts hundreds of adventurers aiming to reach the 8,848-meter peak. As of May 20, 505 climbers had summited Everest this year, including 191 paying clients, 305 Sherpa guides, and seven rope-fixing Sherpas. A total of 468 people from 57 countries were granted Everest permits for the season, contributing $5 million in royalties to the government.

In total, Nepal has issued over 1,100 climbing permits to individuals from 73 nations for various mountain expeditions this year.

MENAFN28052025000045015687ID1109605036


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service